Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producing
Enterobacterales bacteremia in high-risk neutropenic patients
Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producingEnterobacterales bacteremia in high-risk neutropenic patients